-
1
-
-
0026346022
-
Treatment of acute migraine with subcutaneous sumatriptan
-
Cady RK, Wendt JK, Kirchner JR, et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991;265:2831-2835.
-
(1991)
JAMA
, vol.265
, pp. 2831-2835
-
-
Cady, R.K.1
Wendt, J.K.2
Kirchner, J.R.3
-
2
-
-
0027519730
-
Post-marketing study of cardiovascular adverse reactions associated with sumatriptan
-
Ottervanger JP, van Witsen TB, Valkenburg HA, et al. Post-marketing study of cardiovascular adverse reactions associated with sumatriptan. BMJ. 1993;307:1185.
-
(1993)
BMJ
, vol.307
, pp. 1185
-
-
Ottervanger, J.P.1
Van Witsen, T.B.2
Valkenburg, H.A.3
-
3
-
-
0027117826
-
Vasospasm and sumatriptan: Details of 12 cases of chest symptoms after administration of sumatriptan reported to Netherlands Center for Monitoring of Adverse Reactions to Drugs
-
Stricker BH. Vasospasm and sumatriptan: details of 12 cases of chest symptoms after administration of sumatriptan reported to Netherlands Center for Monitoring of Adverse Reactions to Drugs. BMJ. 1992;305:118.
-
(1992)
BMJ
, vol.305
, pp. 118
-
-
Stricker, B.H.1
-
4
-
-
0026562304
-
Coronary vasospasm induced by subcutaneous sumatriptan
-
Willett F, Curzen N, Adams J, et al. Coronary vasospasm induced by subcutaneous sumatriptan. BMJ. 1992;304:1415.
-
(1992)
BMJ
, vol.304
, pp. 1415
-
-
Willett, F.1
Curzen, N.2
Adams, J.3
-
5
-
-
0027509311
-
Effect of subcutaneous sumatriptan, a selective 5HT-1 agonist, on the systemic, pulmonary and coronary circulation
-
MacIntyre PD, Bhargava B, Hogg KJ, et al. Effect of subcutaneous sumatriptan, a selective 5HT-1 agonist, on the systemic, pulmonary and coronary circulation. Circulation. 1993;87:401-405.
-
(1993)
Circulation
, vol.87
, pp. 401-405
-
-
MacIntyre, P.D.1
Bhargava, B.2
Hogg, K.J.3
-
6
-
-
0029435479
-
Oral sumatriptan-associated transmural myocardial infarction
-
O'Connor P, Gladstone P. Oral sumatriptan-associated transmural myocardial infarction. Neurology. 1995;45:2274-2276.
-
(1995)
Neurology
, vol.45
, pp. 2274-2276
-
-
O'Connor, P.1
Gladstone, P.2
-
7
-
-
0029901682
-
Drug treatment of migraine: Acute treatment and migraine prophylaxis
-
Tfelt-Hansen P. Drug treatment of migraine: acute treatment and migraine prophylaxis. Curr Opin Neurol. 1996;9:211-213.
-
(1996)
Curr Opin Neurol
, vol.9
, pp. 211-213
-
-
Tfelt-Hansen, P.1
-
8
-
-
0026445764
-
The effect of IV sumatriptan, a selective 5-HT-1 receptor agonist on central hemodynamics and the coronary circulation
-
MacIntyre PD, Bhargava B, Hogg KJ, et al. The effect of IV sumatriptan, a selective 5-HT-1 receptor agonist on central hemodynamics and the coronary circulation. Br J Pharmacol. 1992;34:541-546.
-
(1992)
Br J Pharmacol
, vol.34
, pp. 541-546
-
-
MacIntyre, P.D.1
Bhargava, B.2
Hogg, K.J.3
-
9
-
-
0025913813
-
Treatment of migraine attacks with sumatriptan
-
The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 1991;325:316-321.
-
(1991)
N Engl J Med
, vol.325
, pp. 316-321
-
-
-
10
-
-
0032524718
-
Cardiac arrest and myocardial infarction immediately after sumatriptan injection
-
Main ML, Ramaswamy K, Andrews TC. Cardiac arrest and myocardial infarction immediately after sumatriptan injection. Ann Intern Med. 1998;128:874.
-
(1998)
Ann Intern Med
, vol.128
, pp. 874
-
-
Main, M.L.1
Ramaswamy, K.2
Andrews, T.C.3
-
11
-
-
0030055536
-
Sumatriptan in clinical practice: A 2-year review of 453 migraine patients
-
Visser WH, Vriend RH, Jaspers MW, et al. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology. 1996;47:46-51.
-
(1996)
Neurology
, vol.47
, pp. 46-51
-
-
Visser, W.H.1
Vriend, R.H.2
Jaspers, M.W.3
-
14
-
-
0031594808
-
5-HT-1D-beta receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina
-
Ishida T, Hirata K, Sakoda T, et al. 5-HT-1D-beta receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina. Chest. 1998;113:243-244.
-
(1998)
Chest
, vol.113
, pp. 243-244
-
-
Ishida, T.1
Hirata, K.2
Sakoda, T.3
|